You are leaving Relmada.com
By clicking YES, you will be directed to another website. Click NO to remain on this page. Do you wish to continue to another website?
Analyst coverage
| Firm | Analyst |
|---|---|
| Goldman Sachs | Salveen Richter, CFA |
| Guggenheim Securities | Yatin Suneja |
| Jefferies | Andrew Tsai |
| SVB Leerink | Marc Goodman |
| Mizuho | Vamil Divan, MD |
| Oppenheimer & Co. | Jay Olson, CFA |
| Truist Securities | Joon Lee, M.D., Ph.D. |
Institutional holders
https://www.nasdaq.com/market-activity/stocks/rlmd/institutional-holdings
Relmada Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Relmada Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Relmada Therapeutics, Inc. or its management. Relmada Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.